îāļāđāļāļŦāļē
îž
î
āļĨāđāļāļāļāļīāļ
îāļāđāļāļŦāļē
î
aTyr Pharma Ord Shs
LIFEîāđāļāļīāđāļĄāļĨāļāđāļāļĢāļēāļĒāļāļēāļĢāļāļīāļāļāļēāļĄ
36.450USD
+0.050+0.14%
āđāļ§āļĨāļēāļāļģāļāļēāļĢāļāļĨāļēāļÂ 09/18, 15:01ïžETïž
2.32BāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
āļāļēāļāļāļļāļP/E TTM
āļĢāļēāļĒāļĨāļ°āđāļāļĩāļĒāļāđāļāļīāđāļĄāđāļāļīāļĄāļāļāļ aTyr Pharma Ord Shs āļāļĢāļīāļĐāļąāļ
Ethos Technologies Inc. is a United States-based life insurance company. The Company offers whole life insurance and term life insurance. Its whole life insurance provides accidental death benefit and death benefit. Its term life insurance offers monthly payment of premiums that do not increase during the term. It is provided for age 65-85 years. Its term life insurance provides coverage for a term typically 10-30 years. The Company operates in every United States and the District of Columbia.
aTyr Pharma Ord Shs āđāļāļĢāđāļāļĨāđ
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļLIFE
āļāļ·āđāļāļāļĢāļīāļĐāļąāļEthos Technologies Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 07, 2015
āļāļĩāļāļĩāđāļColis (Peter George)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ- -
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 07
āļāļĩāđāļāļĒāļđāđ1606 Headway Circle
āđāļĄāļ·āļāļAUSTIN
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ78754
āđāļāļĢāļĻāļąāļāļāđ13026365400
āđāļ§āđāļāđāļāļāđhttps://www.ethos.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļLIFE
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 07, 2015
āļāļĩāļāļĩāđāļColis (Peter George)
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ aTyr Pharma Ord Shs
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, President
Co-Founder, President
842.24K
-6.86%
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, President
Co-Founder, President
842.24K
-6.86%
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, President
Co-Founder, President
842.24K
-6.86%
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
271.52K
+2.60%
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
271.52K
+2.60%
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
271.52K
+2.60%
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Ms. Erin N. Lantz
Ms. Erin N. Lantz
Chief Revenue Officer
Chief Revenue Officer
253.90K
--
Mr. Vipul Sharma
Mr. Vipul Sharma
Chief Technology Officer
Chief Technology Officer
226.62K
+79.34%
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, President
Co-Founder, President
842.24K
-6.86%
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, President
Co-Founder, President
842.24K
-6.86%
Mr. Lingke Wang
Mr. Lingke Wang
Co-Founder, President
Co-Founder, President
842.24K
-6.86%
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
271.52K
+2.60%
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
271.52K
+2.60%
Mr. William J. (Bill) Wheeler
Mr. William J. (Bill) Wheeler
Independent Director
Independent Director
271.52K
+2.60%
āļāļģāļāļēāļĄāļāļĩāđāļāļāļāđāļāļĒ
āđāļāļĢāļāļ·āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ aTyr Pharma Ord Shs?
îāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ aTyr Pharma Ord Shs āđāļāđāđāļāđ: Mr. Lingke Wang
āļĄāļĩāļāļĩāđāļŠāļāļēāļāļąāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ aTyr Pharma Ord Shs (LIFE)?
îāļ āļ§āļąāļāļāļĩāđ 2026Q1 āļĄāļĩāļŠāļāļēāļāļąāļāļāļģāļāļ§āļ 258 āđāļŦāđāļāļāļĩāđāļāļ·āļāļŦāļļāđāļāļāļāļ aTyr Pharma Ord Shs āđāļāļĒāļĄāļĩāļĄāļđāļĨāļāđāļēāļĢāļ§āļĄāļāļĢāļ°āļĄāļēāļ 61.21M āļāļīāļāđāļāđāļ 88.45% āļāļāļāļŦāļļāđāļāļāļąāđāļāļŦāļĄāļ āđāļĄāļ·āđāļāđāļāļĩāļĒāļāļāļąāļāļ§āļąāļāļāļĩāđ 2025Q4 āļāļēāļĢāļāļ·āļāļŦāļļāđāļāļāļāļāļŠāļāļēāļāļąāļāđāļāđāđāļāļīāđāļĄāļāļķāđāļ -10216639.00